Answers are grounded in this paper and cite their sources.
CD46 (also known as membrane cofactor protein or MCP) is a regulator of complement activation that is expressed in most or all human nucleated cell types. CD46 was initially identified as binding and inactivating C3b and C4b complement products, a process protecting human cells from lysis by autologous complement (18). It also serves as a receptor for several human pathogens: an enveloped RNA virus (measles virus [MV]), an enveloped DNA virus (human herpesvirus 6), a nonenveloped DNA virus (adenovirus of different serotypes), and two types of bacteria (Streptococcus pyogenes and pathogenic Neisseria) (13, 27). Moreover, bovine CD46 was recently shown to serve as a receptor for bovine viral diarrhea virus (BVDV), an enveloped RNA virus. That six different pathogens selected the same molecule as a port of cell entry is of interest not only for microbiologists and immunologists, who wonder what makes CD46 such a seductive molecule, but also for gene therapists, who are seeking opportunities for targeting disease sites.
No takes yet. Share an insight, caveat, or question.
Roberto Cattaneo (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: